Moderna’s stock slides as it slashes research spending, trims pipeline
MarketWatchModerna Inc.’s stock fell more than 12% premarket on Thursday after the company said it will rein in its research-and-development spending and trim its pipeline as it looks to shake off the doldrums of a dwindling COVID vaccine market.